Streetbeat News

Analyst Ratings

ATLC

JMP Securities analyst David Scharf has reiterated a Market Outperform rating on Atlanticus Holdings (NASDAQ:ATLC) and maintained a $48 price target.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 12:47 pm

COCP

Cocrystal Pharma reported Q2 losses of $(0.50) per share, beating the analyst consensus estimate of $(0.58) by 13.79%. However, this is a 4.17% increase in losses compared to the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:46 pm

AAPL

FXCOF

Apple Inc.'s key supplier, Foxconn Technology Co. Ltd., predicts a decline in iPhone demand in 2023, which could lead to a weak holiday season for Apple. This is due to an expected slowdown in the global smartphone industry. Apple is expected to see a 2% decline in iPhone revenue in September, the largest fall since 2016. However, Apple might offset some of this impact with an expected $100 increase in iPhone 15 Pro and iPhone 15 Pro Max prices.

Portfolio Pulse from Rounak Jain

August 14, 2023 | 12:46 pm

ANIK

Barrington Research analyst Michael Petusky has upgraded Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform and set a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:46 pm

XP

XP Inc. is expected to report higher Q2 earnings with an estimate of 38 cents per share, up from 35 cents per share a year ago. Revenue is projected at $720.6 million, compared to $641.29 million in the same period last year. XP shares fell 1.4% to close at $25.32 on Friday. Analysts from B of A Securities, Banco Bradesco BBI SA, and Citigroup have recently changed their ratings and price targets for the stock.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 12:46 pm

TRIP

TD Cowen analyst Kevin Kopelman has maintained a 'Market Perform' rating on TripAdvisor (NASDAQ:TRIP) and lowered the price target from $18 to $16.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 14, 2023 | 12:45 pm

PGY

Canaccord Genuity analyst Joseph Vafi maintains a 'Buy' rating on Pagaya Techs (NASDAQ:PGY) and raises the price target from $3 to $3.5.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 12:45 pm

INDP

Indaptus Therapeutics reported Q2 losses of $(0.39) per share, beating the analyst consensus estimate of $(0.58) by 32.76 percent. This represents a 15.22 percent increase over losses from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:43 pm

GPRK

Canaccord Genuity analyst Jenny Xenos has reiterated a 'Buy' rating on GeoPark (NYSE:GPRK) and maintained a price target of $15.5.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 12:43 pm

EQR

Truist Securities analyst Michael Lewis maintains a Buy rating on Equity Residential (NYSE:EQR) and raises the price target from $71 to $77.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 14, 2023 | 12:42 pm